The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AILERON THERAPEUTICS INC | COM | 00887A105 | 538 | 517,558 | SH | SOLE | 517,558 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 63,776 | 1,114,962 | SH | SOLE | 1,114,962 | 0 | 0 | ||
ATEA PHARMACEUTICALS INC | COM | 04683R106 | 85,621 | 2,049,331 | SH | SOLE | 2,049,331 | 0 | 0 | ||
BELLICUM PHARMACEUTICALS INC | COM NEW | 079481404 | 91 | 25,651 | SH | SOLE | 25,651 | 0 | 0 | ||
CLEARSIDE BIOMEDICAL INC | COM | 185063104 | 2,174 | 793,555 | SH | SOLE | 793,555 | 0 | 0 | ||
KEZAR LIFE SCIENCES INC | COM | 49372L100 | 673 | 128,916 | SH | SOLE | 128,916 | 0 | 0 | ||
KYMERA THERAPEUTICS INC | COM | 501575104 | 43,652 | 704,059 | SH | SOLE | 704,059 | 0 | 0 | ||
MOLECULAR TEMPLATES INC | COM | 608550109 | 1,923 | 204,809 | SH | SOLE | 204,809 | 0 | 0 | ||
RAPT THERAPEUTICS INC | COM | 75382E109 | 2,143 | 108,503 | SH | SOLE | 108,503 | 0 | 0 | ||
SEER INC | COM CL A | 81578P106 | 59,866 | 1,066,375 | SH | SOLE | 1,066,375 | 0 | 0 | ||
SUTRO BIOPHARMA | COM | 869367102 | 3,799 | 175,000 | SH | SOLE | 175,000 | 0 | 0 |